Good evening :)
Place Order
Add to Watchlist

Biogen Pharmachem Industries Ltd

BIOGEN

Biogen Pharmachem Industries Ltd

BIOGEN
UtilitiesIndependent Power Producers & Energy Traders
SmallcapWith a market cap of ₹84 cr, stock is ranked 3,148
High RiskStock is 4.61x as volatile as Nifty
1.272.31% (-0.03)
1.272.31% (-0.03)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
UtilitiesIndependent Power Producers & Energy Traders
SmallcapWith a market cap of ₹84 cr, stock is ranked 3,148
High RiskStock is 4.61x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

UtilitiesIndependent Power Producers & Energy Traders
SmallcapWith a market cap of ₹84 cr, stock is ranked 3,148
High RiskStock is 4.61x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
61.481.50
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
23.183.511.27%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Techno Overseas Ltd. invests and trades in shares and securities. It trades in commodities, including agro based and precious metals, and other goods in present and future markets.

Peers

Hmm, looks like data is unavailable here. Please come back after some time
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Matching Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 20.16%, vs industry avg of 20.16%

Constant Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 100%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.000.000.160.950.001.622.480.912.381.54
Raw Materialssubtract0.020.16
Power & Fuel Costsubtract
Employee Costsubtract0.010.030.040.040.010.050.170.08
Selling & Administrative Expensessubtract
Operating & Other expensessubtract0.126.690.920.083.212.430.280.37
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.00
Interest & Other Itemssubtract
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.00
EPS-0.00-0.00-0.10-0.00-0.00-0.020.000.010.030.02
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Hmm, looks like data is unavailable here. Please come back after some time.

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.00%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding0.00%0.00%0.00%0.00%100.00%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BIOGEN has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Biogen Pharmachem Industries to announce Quarterly Result

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to convene AGM

Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to hold AGM

Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Biogen Pharmachem Industries revises board meeting date

Biogen Pharmachem Industries has revised the meeting of the Board of Directors which was scheduled to be held on 9 August 2024. The meeting will now be held on 13 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to conduct board meeting

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Biogen Pharmachem Industries reports standalone net loss of Rs 0.16 crore in the June 2024 quarter

Net loss of Biogen Pharmachem Industries reported to Rs 0.16 crore in the quarter ended June 2024 as against net profit of Rs 0.41 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Biogen Pharmachem Industries to conduct board meeting

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

BRIEF-Sun Techno Overseas Approves Appointment Of Akshay Makadiya As CFO - Investing.com India

3 years agoInvesting.com